| Cash flow (USD) | Q2 2026 ended Jun 30, 2026 | Q1 2026 ended Mar 31, 2026 | Q4 2025 ended Dec 31, 2025 | Q3 2025 ended Sep 30, 2025 | Q2 2025 ended Jun 30, 2025 | Q1 2025 ended Mar 31, 2025 | Q4 2024 ended Dec 31, 2024 | Q3 2024 ended Sep 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Net income | 84.29M | 148.77M | 75.53M | 55.84M | 28.21M | 29.54M | 54.58M | -8.23M |
| Depreciation and amortization | 41.42M | 39.09M | 39.52M | 40.75M | 41.84M | 42.16M | 54.88M | 50.61M |
| Stock-based compensation | 19.49M | 3.68M | 14.37M | 17.25M | 22.80M | 15.68M | 13.98M | 15.21M |
| Cash from operations | 43.92M | 122.94M | 231.56M | 107.94M | 49.08M | 101.60M | 90.61M | 27.25M |
| Capital expenditure | -29.03M | -21.54M | -37.66M | -15.76M | -24.43M | -17.63M | -15.31M | -20.04M |
| Free cash flow | 14.88M | 101.40M | 193.89M | 92.17M | 24.65M | 83.97M | 75.30M | 7.20M |
| Acquisitions | 0 | -42.20M | -196.26M | -1.55M | 0 | -6.75M | -42.0K | -16.14M |
| Cash from investing | -28.20M | 747.39M | -233.88M | -23.76M | -23.24M | -24.19M | -15.78M | -35.83M |
| Share buybacks | -60.00M | -60.00M | 0 | 0 | ||||
| Net debt issued | -308.14M | -12.35M | -12.34M | -14.21M | -11.93M | -11.79M | -11.70M | -13.66M |
| Cash from financing | -354.13M | -70.02M | -50.50M | -13.11M | -8.24M | -86.02M | -49.55M | 19.53M |
| Net change in cash | -338.42M | 800.32M | -52.82M | 71.07M | 17.59M | -8.61M | 25.28M | 10.95M |
From BrightSpring Health Services, Inc.'s 10-K and 10-Q filings with the SEC. Fourth quarters, and quarters where the company only reported year-to-date totals, are worked out by subtracting the earlier quarters. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read cash flow or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.